FDA approves novel treatment targeting abnormality in sickle cell disease

被引：0

|

作者：

不详

机构：

来源：

NURSE PRACTITIONER | 2020年 / 45卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

引用

收藏

页码：56 / 56

页数：1

相关论文

共 50 条

[1] FDA approves sickle cell drug
Brainard, Jeffrey
SCIENCE, 2019, 366 (6470) : 1174 - 1174
[2] FDA Approves 2 Gene Therapies to Treat Sickle Cell Disease
Verdun, Nicole
AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (02):
[3] FDA approves first treatment for Fabry disease
不详
LABORATORY MEDICINE, 2003, 34 (06) : 429 - 430
[4] FDA approves first new sickle cell drug in 20 years
Asher Mullard
Nature Reviews Drug Discovery, 2017, 16 : 519 - 519
[5] FDA approves first new sickle cell drug in 20 years
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (08) : 519 - 519
[6] US FDA approves first drug for sickle-cell anaemia
Ault, A
LANCET, 1998, 351 (9105): : 809 - 809
[7] Targeting novel mechanisms of pain in sickle cell disease
Huy Tran
Gupta, Mihir
Gupta, Kalpna
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 546 - 555
[8] Targeting novel mechanisms of pain in sickle cell disease
Huy Tran
Gupta, Mihir
Gupta, Kalpna
BLOOD, 2017, 130 (22) : 2377 - 2385
[9] NOVEL THERAPIES TARGETING THE ENDOTHELIUM IN SICKLE CELL DISEASE
Hoppe, Carolyn C.
HEMOGLOBIN, 2011, 35 (5-6) : 530 - 546
[10] FDA fully approves new Alzheimer disease treatment
不详
NURSE PRACTITIONER, 2023, 48 (09): : 48 - 48

← 1 2 3 4 5 →